Concepedia

Somi Reddy Majjigapu

SR

Statistics

Publications

8

Citations

439

H-Index

8

Active since

2012

Affiliations

University of Lausanne(Current)

École Polytechnique Fédérale de Lausanne

University Hospital of Lausanne

SIB Swiss Institute of Bioinformatics

Ludwig Cancer Research

Somi Reddy Majjigapu is an author at University of Lausanne specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

2012–2022

8

Publications

8

Rational Design of 4-Aryl-1,2,3-Triazoles for Indoleamine 2,3-Dioxygenase 1 Inhibition

Ute F. Röhrig, Somi Reddy Majjigapu, Aurélien Grosdidier et al. · Journal of Medicinal Chemistry · 2012 · 167 citations · Full text

Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1)

Ute F. Röhrig, A. Reynaud, Somi Reddy Majjigapu et al. · Journal of Medicinal Chemistry · 2019 · 81 citations · Full text

, , +17

Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors

Ute F. Röhrig, Somi Reddy Majjigapu, Marc Chambon et al. · European Journal of Medicinal Chemistry · 2014 · 69 citations · Full text

, , +7

1,2,3-Triazoles as inhibitors of indoleamine 2,3-dioxygenase 2 (IDO2)

Ute F. Röhrig, Somi Reddy Majjigapu, Daniela Caldelari et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 41 citations · Full text

, , +7

A critical role of autophagy in antileukemia/lymphoma effects of APO866, an inhibitor of NAD biosynthesis

Vanessa Ginet, Julien Puyal, Coralie Rummel et al. · Autophagy · 2014 · 38 citations · Full text

, , +18

1–5 of 8